Comparative efficacy in smokers with versus without COPD: a new addition of an old drug to approved pharmacotherapy for smoking cessation

By afschroeder • October 31, 2025

Tashkin DP, Melamed KH. Comparative efficacy in smokers with versus without COPD: a new addition of an old drug to approved pharmacotherapy for smoking cessation. Thorax. 2025 Oct 30:thorax-2025-224162. doi: 10.1136/thorax-2025-224162. Epub ahead of print. PMID: 41167618.

Tags: COPD Pharmacology, Publications, Pulmonary, Critical Care & Sleep Medicine, Smoking cessation

Clonal Hematopoiesis and Major Adverse Cardiac Events in People With HIV: Insights From the REPRIEVE Trial

Xue L, Bhattacharya R, Uddin MM, Nakao T, Zou R, Patel A, Haidermota S, Niroula A, Viscosi V, Postupaka D, Bhatnagar A, Finneran P, Bernardo[...]

IDH2 mutation is associated with favorable outcome among older adults with newly diagnosed acute myeloid leukemia treated with hypomethylating agent-based therapy

Hoff FW, Huang Y, Welkie RL, Swords RT, Traer E, Stein EM, Lin TL, Baer MR, Duong VH, Blum WG, Arellano ML, Stock W, Odenike[...]

L-arginine Results in an Artificial Increase in Creatinine

Hwang M, Han J, Lei S, Kagan I. L-arginine Results in an Artificial Increase in Creatinine. Cureus. 2025 Oct 5;17(10):e93866. doi: 10.7759/cureus.93866. PMID: 41194845; PMCID:[...]